Literature DB >> 20582515

Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria.

Takanori Sakaguchi1, Shohachi Suzuki, Yoshifumi Morita, Kousuke Oishi, Atsushi Suzuki, Kazuhiko Fukumoto, Keisuke Inaba, Satoshi Nakamura, Hiroyuki Konno.   

Abstract

PURPOSE: Hepatectomy is feasible for patients with hepatocellular carcinoma (HCC) who are eligible for liver transplantation according to the Milan criteria if they have good hepatic function. This retrospective study investigates the prognostic factors of hepatectomy in HCC patients meeting the Milan criteria.
METHODS: Between 1991 and 2005, 175 patients underwent hepatectomy for HCC at our institute; 111 met and 64 exceeded the Milan criteria. The prognostic factors for hepatectomy were investigated using a Cox regression model.
RESULTS: Operative mortality and morbidity were significantly lower in the patients who met the criteria than in those who exceeded the criteria. After a median follow-up of 51.5 months, the 5-year survival rate was significantly better for the patients who met the criteria than for those who exceeded the criteria (77.8% vs 35.7%; P < 0.0001). The factors predictive of poor prognosis were poor differentiation, microscopic vasculobiliary invasion, and a high serum des-gamma-carboxy prothrombin (DCP) level (>100 mAU/ml) for the patients who met the Milan criteria; and only the presence of a microsatellite lesion for the patients who did not meet the Milan criteria.
CONCLUSIONS: Hepatectomy is safe and beneficial for HCC patients who meet the Milan criteria, but a high preoperative serum DCP level may be predictive of a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20582515     DOI: 10.1007/s00595-009-4109-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  19 in total

1.  High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

Authors:  Margarita Sala; Josep Fuster; Josep M Llovet; Miquel Navasa; Manel Solé; María Varela; Fernando Pons; Antoni Rimola; Juan Carlos García-Valdecasas; Concepció Brú; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

2.  Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.

Authors:  Carlos Margarit; Alfredo Escartín; Lluis Castells; Víctor Vargas; Elena Allende; Itxarone Bilbao
Journal:  Liver Transpl       Date:  2005-10       Impact factor: 5.799

3.  Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.

Authors:  Saburo Fukuda; Toshiyuki Itamoto; Hideki Nakahara; Toshihiko Kohashi; Hideki Ohdan; Hiroshi Hino; Makoto Ochi; Hirotaka Tashiro; Toshimasa Asahara
Journal:  Hepatogastroenterology       Date:  2005 Jul-Aug

4.  Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Authors:  Y Koike; Y Shiratori; S Sato; S Obi; T Teratani; M Imamura; H Yoshida; S Shiina; M Omata
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

5.  Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.

Authors:  H H Lee; J W Joh; J H Park; K W Lee; J S Heo; S H Choi; S J Kim; S K Lee
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

6.  Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma.

Authors:  H Imamura; Y Matsuyama; Y Miyagawa; K Ishida; R Shimada; S Miyagawa; M Makuuchi; S Kawasaki
Journal:  Br J Surg       Date:  1999-08       Impact factor: 6.939

7.  Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test.

Authors:  Hiroshi Imamura; Keiji Sano; Yasuhiko Sugawara; Norihiko Kokudo; Masatoshi Makuuchi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

8.  Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria.

Authors:  Junji Yamamoto; Tomoo Kosuge; Akio Saiura; Yoshihiro Sakamoto; Kazuaki Shimada; Tsuyoshi Sano; Tadatoshi Takayama; Yasuhiko Sugawara; Toshiharu Yamaguchi; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Jpn J Clin Oncol       Date:  2007-04       Impact factor: 3.019

9.  Evolution of living donor liver transplantation over 10 years: experience of a single center.

Authors:  Susumu Eguchi; Mitsuhisa Takatsuki; Masaaki Hidaka; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Surg Today       Date:  2008-08-28       Impact factor: 2.549

10.  Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization.

Authors:  Toshiya Kamiyama; Kazuaki Nakanishi; Hideki Yokoo; Hirofumi Kamachi; Munenori Tahara; Tomomi Suzuki; Tsuyoshi Shimamura; Hiroyuki Furukawa; Michiaki Matsushita; Satoru Todo
Journal:  Ann Surg Oncol       Date:  2009-03-04       Impact factor: 5.344

View more
  8 in total

Review 1.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 2.  Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.

Authors:  Ken Shirabe; Yohei Mano; Jun Muto; Rumi Matono; Takashi Motomura; Takeo Toshima; Kazuki Takeishi; Hidekaki Uchiyama; Tomoharu Yoshizumi; Akinobu Taketomi; Masaru Morita; Shunichi Tsujitani; Yoshihisa Sakaguchi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-25       Impact factor: 2.549

3.  Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.

Authors:  Tomoki Ryu; Yuko Takami; Yoshiyuki Wada; Masaki Tateishi; Hajime Matsushima; Kazuhiro Mikagi; Hideki Saitsu
Journal:  J Gastrointest Surg       Date:  2017-03-15       Impact factor: 3.452

4.  Interleukin-12 inhibits the hepatocellular carcinoma growth by inducing macrophage polarization to the M1-like phenotype through downregulation of Stat-3.

Authors:  Qin Wang; Feng Cheng; Ting-Ting Ma; Hai-Yu Xiong; Zi-Wei Li; Chang-Li Xie; Cui-Ying Liu; Zhi-Guang Tu
Journal:  Mol Cell Biochem       Date:  2016-03-22       Impact factor: 3.396

Review 5.  Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer.

Authors:  Margherita Correnti; Chiara Raggi
Journal:  Oncotarget       Date:  2017-01-24

6.  Role of S100A3 in human hepatocellular carcinoma and the anticancer effect of sodium cantharidinate.

Authors:  Ran Tao; Zhong-Feng Wang; Wei Qiu; Yu-Fang He; Wei-Qun Yan; Wen-Yi Sun; Hai-Jun Li
Journal:  Exp Ther Med       Date:  2017-04-04       Impact factor: 2.447

7.  Methyl-Cantharidimide Inhibits Growth of Human Hepatocellular Carcinoma Cells by Inducing Cell Cycle Arrest and Promoting Apoptosis.

Authors:  Xiangzhong Huang; Wen Xie; Xiaofan Yu; Caiyun Fan; Jin Wang; Yi Cao; Jianxiang Li
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

8.  Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Xin-Shao Mo; Bang-De Xiang; Wei-Ping Yuan; Jin-Fang Jiang; Gui-Sheng Xie; Le-Qun Li
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.